EUCTR2007-003957-10-GB进行中（未招募）1 期
Short Course Oncology Therapy - A study of adjuvant chemotherapy in colorectal cancer - SCOT study
Greater Glasgow Health Board (GGHB)/ University of Glasgow0 个研究点目标入组 6,144 人开始时间: 2007年12月13日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 6,144
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Fully resected stage III colorectal cancer*
- •Fully resected high-risk stage II colorectal cancer* (defined as having one or more of the following - T4 disease, tumour obstruction and/or perforation of the primary tumour during the pre-operative period, inadequate nodal harvest as indicated by <10 nodes examined, poorly differentiated histology, perineural invasion, peritoneal involvement or extramural venous/lymphatic invasion).
- •No evidence of residual or metastatic disease.
- •Ideally patients should be randomised within 11 weeks of surgery and treatment should start within 2 weeks of randomisation. However as long as the surgery to cycle 1 treatment start date is = 13 weeks the patient will be considered eligible.
- •WHO PS = 0 or 1.
- •Age >18 years.
- •Life expectancy >5 years with reference to non-cancer related diseases.
- •Written informed consent.
- •CEA = 1.2 X ULN (as per local values)
- •Patients with rectal cancer will be eligible unless they have had pre-operative combined chemotherapy and radiotherapy, or are scheduled for post-operative combined chemotherapy and radiotherapy.
- •All rectal cancer patients included in the trial must have had TME type surgery with negative (R0) resection margins (R0 defined as greater than 1mm clearance).
- •* All patients must have negative (R0) resection margins defined as greater than 1mm clearance.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years)
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years)
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Previous chemotherapy*.
- •Previous long course chemoradiotherapy (pre-operative short course radiotherapy is allowed).
- •Moderate/severe renal impairment (GFR/Creatinine Clearance <30 ml/min), as calculated by the Cockcroft-Gault equation.
- •Absolute neutrophil count<1.5x109/L.
- •Platelet count <100x109/L.
- •Haemoglobin <9 g/dL.
- •Aspartate aminotransferase/Alanine aminotransferase >2.5 x upper limit of normal (at least one of AST or ALT must be performed).
- •Clinically significant cardiovascular disease. [i.e. active; or <12 months since e.g. cerebrovascular accident, myocardial infarction, unstable angina, New York Heart Association (NYHA – Appendix 4) grade II or greater congestive heart failure, serious cardiac arrhythmia requiring medication, uncontrolled hypertension].
- •Pregnancy/lactation or of child bearing potential and not using, or willing to use medically approved contraception. (Postmenopausal women must have been amenorrheic for at least 12 months to be considered of non-childbearing potential.)
- •Previous malignancy other than adequately treated in situ carcinoma of the uterine cervix or basal or squamous cell carcinoma of the skin, unless there has been a disease-free interval of at least 5 years.
- •Known or suspected dihydropyrimidine dehydrogenase (DPD) deficiency.
- •* No previous chemotherapy except chemotherapy administered with curative intent completed more than 5 years ago and from which there are no residual complications.
研究者
相似试验
进行中（未招募）
1 期
Short Course Oncology Therapy - A study of adjuvant chemotherapy in colorectal cancer - SCOT studyColorectal CancerMedDRA version: 14.1 Level: PT Classification code 10010034 Term: Colorectal cancer stage III System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1 Level: PT Classification code 10010033 Term: Colorectal cancer stage II System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2007-003957-10-SEGastrointestinal Onkologisk Förening9,500
进行中（未招募）
不适用
Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal CancerColorectal Cancer in Remission (Disease postoperativ)EUCTR2007-003957-10-DEGreater Glasgow Health Board/University of Glasgow (GU)9,500
尚未招募
不适用
A study comprising of chemotherapy and radiotherapy before the surgery of locally advanced rectal cancer.CTRI/2019/08/020847AIIMS New Delhi
尚未招募
不适用
Follow up study of adjuvant chemotherapy trial of S-1 for breast cancer with ER-positive and HER2-negativeBreast CancerJPRN-UMIN000039606Department of Breast Surgery, Graduate school of medicine, Kyoto University1,930
已完成
3 期
Short Course Oncology Therapy. A study of adjuvant chemotherapy in colorectal cancer.Cancer - Bowel - Back passage (rectum) or large bowel (colon)Colon CancerACTRN12609000662268Australasian Gastrointestinal Trials Group (AGITG)213